Tenax Therapeutics (TENX) Institutional Ownership $6.75 +0.62 (+10.11%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$6.72 -0.03 (-0.44%) As of 02/21/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tenax Therapeutics (NASDAQ:TENX)CurrentInstitutional OwnershipPercentage1.67%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$1.88MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$345.86K Get TENX Insider Trade Alerts Want to know when executives and insiders are buying or selling Tenax Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TENX Institutional Buying and Selling by Quarter Tenax Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Vestal Point Capital LP55,189$342K0.0%-33.8%1.618% 2/17/2025 Two Sigma Investments LP13,521$84K0.0%N/A0.397% 2/17/2025 Millennium Management LLC26,809$166K0.0%N/A0.786% 2/17/2025 Janus Henderson Group PLC166,666$1.03M0.0%N/A4.888% 2/13/2025 ADAR1 Capital Management LLC34,693$215K0.0%-44.4%1.017% 2/12/2025 Geode Capital Management LLC24,354$151K0.0%+32.4%0.714% 11/15/2024 Sphera Funds Management LTD.29,166$101K0.0%N/A0.855% 11/14/2024 Vestal Point Capital LP83,333$288K0.0%N/A2.444% 11/14/2024 Stonepine Capital Management LLC50,000$173K0.1%N/A1.466% 5/1/2023 Virtu Financial LLC84,361$39K0.0%N/A0.377% 11/14/2022 Armistice Capital LLC1,965,885$334K0.0%+23.1%7.799% 11/5/2021 PNC Financial Services Group Inc.70,000$124K0.0%N/A0.278% 10/13/2021Gofen & Glossberg LLC IL3,819,170$6.76M0.2%N/A15.155% 8/16/2021 State Street Corp136,404$296K0.0%N/A0.911% 8/13/2021 Renaissance Technologies LLC192,232$400K0.0%-74.3%1.284% 8/13/2021 Northern Trust Corp34,671$72K0.0%+103.7%0.232% 8/13/2021 Vanguard Group Inc.356,347$742K0.0%+100.3%2.381% 8/12/2021 Dimensional Fund Advisors LP51,895$113K0.0%-14.1%0.347% 5/21/2021 Citadel Advisors LLC15,964$30K0.0%-41.4%0.107% 5/18/2021 Citadel Advisors LLC15,964$30K0.0%-41.4%0.107% 5/14/2021 Dimensional Fund Advisors LP60,412$115K0.0%N/A0.404% 5/13/2021 Renaissance Technologies LLC747,832$1.42M0.0%+75.1%4.996% 5/12/2021 Geode Capital Management LLC52,301$99K0.0%+58.5%0.349% 2/10/2021 Renaissance Technologies LLC427,032$794K0.0%-19.0%3.384% (Data available from 1/1/2016 forward) TENX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TENX shares? During the previous two years, 9 institutional investors and hedge funds held shares of Tenax Therapeutics. The most heavily invested institutionals were Janus Henderson Group PLC ($1.03M), Vestal Point Capital LP ($342K), ADAR1 Capital Management LLC ($215K), Stonepine Capital Management LLC ($173K), Millennium Management LLC ($166K), Geode Capital Management LLC ($151K), and Sphera Funds Management LTD. ($101K).Learn more on TENX's institutional investors. What percentage of Tenax Therapeutics stock is owned by institutional investors? 1.67% of Tenax Therapeutics stock is owned by institutional investors. Learn more on TENX's institutional investor holdings. Which institutional investors have been buying Tenax Therapeutics stock? The following institutional investors have purchased Tenax Therapeutics stock in the last 24 months: Janus Henderson Group PLC ($166.67K), Virtu Financial LLC ($84.36K), Vestal Point Capital LP ($83.33K), Stonepine Capital Management LLC ($50K), Sphera Funds Management LTD. ($29.17K), Millennium Management LLC ($26.81K), and Two Sigma Investments LP ($13.52K). How much institutional buying is happening at Tenax Therapeutics? Institutional investors have bought a total of 459,820 shares in the last 24 months. This purchase volume represents approximately $5.02M in transactions. Which Tenax Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Tenax Therapeutics stock in the last 24 months: Vestal Point Capital LP ($28.14K), and ADAR1 Capital Management LLC ($27.73K). How much institutional selling is happening at Tenax Therapeutics? Institutional investors have sold a total of 55,874 shares in the last 24 months. This volume of shares sold represents approximately $345.86K in transactions. Related Companies Metagenomi Major Shareholders Elutia Major Shareholders Oramed Pharmaceuticals Major Shareholders MediciNova Major Shareholders Alpha Cognition Major Shareholders Skye Bioscience Major Shareholders Tenaya Therapeutics Major Shareholders Cue Biopharma Major Shareholders Vor Biopharma Major Shareholders SELLAS Life Sciences Group Major Shareholders This page (NASDAQ:TENX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TENX Stock Alerts